Literature DB >> 1116102

Biological markers in breast carcinoma. I. Incidence of abnormalities of CEA, HCG, three polyamines, and three minor nucleosides.

D C Tormey, T P Waalkes, D Ahmann, C W Gehrke, R W Zumwatt, J Snyder, H Hansen.   

Abstract

Patients with breast carcinoma were screened for abnormal concentrations of CEA, HCG, putrescine, spermidine, spermine, pseudouridine, N2, N2-dimethylguanosine, and 1-methylinosine. Abnormal polyamine levels occurred in less than 15% of the patients. Among the nucleosides, N2, N2-dimethylguanosine was the most frequently abnormal, occurring in 57% of the patients with metastatic disease. CEA levels were abnormal in 30% of postoperative N+ patients and 74% of patients with metastatic disease, while HCG elevations were found in 45% and 50%, respectively. All the patients with one or more marker abnormalities could be detected by measuring only CEA, N2, N2-dimethylguanosine, and HCG. Among these three tests, a singular marker abnormality occurred in 35.8% of the patients, and all three tests were abnormal in 21.8% of the patients. The performance of these three tests in each patient revealed one or more abnormalities 97% of the patients with metastatic disease, and 67% of the postoperative N+ patients.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1116102     DOI: 10.1002/1097-0142(197504)35:4<1095::aid-cncr2820350412>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Tumour markers in breast cancer.

Authors: 
Journal:  Br Med J       Date:  1979-04-21

2.  Targeted Profiling of Epitranscriptomic Reader, Writer, and Eraser Proteins Accompanied with Radioresistance in Breast Cancer Cells.

Authors:  Tianyu F Qi; Weili Miao; Yinsheng Wang
Journal:  Anal Chem       Date:  2022-01-12       Impact factor: 6.986

3.  Monitoring serum CEA in women with primary breast tumours positive for oestrogen receptor and with spread to lymph nodes.

Authors:  J C van der Linden; J P Baak; T Postma; J Lindeman; C J Meyer
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

4.  Preoperative carcinoembryonic antigen levels correlated with postoperative pathological staging in bronchial carcinoma.

Authors:  J F Paone; A Kardana; G T Rogers; J Dhasmana; K Jeyasingham
Journal:  Thorax       Date:  1980-12       Impact factor: 9.139

Review 5.  Carcinoembryonic antigen in patients with breast or colon cancer.

Authors:  Y N Lee
Journal:  West J Med       Date:  1978-11

6.  An enzymatic differential assay for urinary diamines, spermidine, and spermine.

Authors:  S Otsuji; Y Soejima; K Isobe; H Yamada; S Takao; M Nishi
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

Review 7.  Polyamine metabolism and cancer: treatments, challenges and opportunities.

Authors:  Robert A Casero; Tracy Murray Stewart; Anthony E Pegg
Journal:  Nat Rev Cancer       Date:  2018-11       Impact factor: 60.716

Review 8.  High level of beta-hCG simulating pregnancy in recurrent osteosarcoma: case report and review of literature.

Authors:  B Leidinger; S Bielack; G Koehler; V Vieth; W Winkelmann; G Gosheger
Journal:  J Cancer Res Clin Oncol       Date:  2004-03-24       Impact factor: 4.553

9.  Tumour markers in breast cancer.

Authors:  D H Cove; K L Woods; S C Smith; D Burnett; J Leonard; R J Grieve; A Howell
Journal:  Br J Cancer       Date:  1979-11       Impact factor: 7.640

10.  Carcinoembryonic antigen in serum of unselected breast-cancer patients and of non-hospitalized controls.

Authors:  A Rimsten; H O Adami; B Wahren; B Nordin
Journal:  Br J Cancer       Date:  1979-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.